Zenas Biopharma IncZBIO
Price$26.97

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1M-80.0% YoYTTM through 30 Jun 2026
Net Income -$484.4MTTM through 30 Jun 2026
Free Cash Flow -$226MTTM through 30 Jun 2026

Margins

Current
Operating Margin-3,830.6%
Net Margin-48,438.4%

Returns

-156.0%ROE
-98.5%ROA

Balance Sheet Health

Debt / Equity0.32x
Current Ratio5.61x
Net Debt-$264.6Mnet cash position
Cash & Equivalents$196.6M

Quality Metrics

Altman Z-Score-0.30
Piotroski F-Score1 / 9
FCF Margin-22,597.4%
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'23'24'25
FY2025: $10M
Diluted EPS-$9.63TTM
'23'24'25
FY2025: $-8.44

Dividend

No dividend

Capital Allocation

Capex Intensity0.2%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.